COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
This AHA Special Bulletin provides details on the Department of Health and Human Services鈥 announcement that it has expanded the providers eligible for its Public Health and Social Services Emergency Fund 鈥淕eneral Distribution.鈥
Thank you for your continued heroic work to care for your communities as our nation battles the COVID-19 pandemic. As you likely know, the Department of Health and Human Services (HHS) has requested that all hospitals report certain data on bed capacity, utilization, personal protective equipment (鈥
The Food and Drug Administration authorized the emergency use of George Washington University Public Health Laboratory鈥檚 GWU SARS-CoV-2 RT-PCR Test.
The Centers for Medicare & Medicaid Services announced the extension of its Appropriate Use Criteria testing period through 2021.
The Food and Drug Administration revoked its emergency use authorization for a SARS-CoV-2 antibody test made by Autobio Diagnostics Co. due to concerns with the accuracy of the test when evaluated at the National Institutes of Health鈥檚 Frederick National Laboratory for Cancer Research.
The Centers for Disease Control and Prevention released a report describing the characteristics of multisystem inflammatory syndrome (MIS-C), a rare but serious condition that states have reported in more than 500 children with COVID-19.
The Food and Drug Administration Tuesday authorized the emergency use of three types of ventilator accessories for treating COVID-19 patients.
The Centers for Medicare & Medicaid Services does not intend for Paycheck Protection Program funds to impact Medicare payments to rural hospitals, CMS Administrator Seema Verma said in a tweet.
Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled 鈥渋n-use time鈥 for refrigerated storage or two hours beyond the labeled 鈥渋n-use time鈥 for room temperature鈥
The National Institutes of Health announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.